JOURNAL OF GERONTOLOGY AND GERIATRICS
https://www.jgerontology-geriatrics.com/
<div class="section "><label for="description-localization-popover-container-5dc00ec6337c8">Journal summary</label> - inglese</div> <div class="section "> <div> <h2>Cos’è Lorem Ipsum?</h2> <p><strong>Lorem Ipsum</strong> è un testo segnaposto utilizzato nel settore della tipografia e della stampa. Lorem Ipsum è considerato il testo segnaposto standard sin dal sedicesimo secolo, quando un anonimo tipografo prese una cassetta di caratteri e li assemblò per preparare un testo campione. È sopravvissuto non solo a più di cinque secoli, ma anche al passaggio alla videoimpaginazione, pervenendoci sostanzialmente inalterato. Fu reso popolare, negli anni ’60, con la diffusione dei fogli di caratteri trasferibili “Letraset”, che contenevano passaggi del Lorem Ipsum, e più recentemente da software di impaginazione come Aldus PageMaker, che includeva versioni del Lorem Ipsum.</p> </div> </div>Pacini Editore Srlen-USJOURNAL OF GERONTOLOGY AND GERIATRICS2499-6564<p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP STATEMENT FORM</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>The corresponding author must sign the </strong></span></span></span><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Authorship Statement Form</strong></span></span></span></a><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>, save it in .pdf and return it by uploading at our submission platform </strong></span></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>http://www.jgerontology-geriatrics.com</strong></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP RESPONSIBILITY</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2) The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted “Journal of Gerontology and Geriatrics” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles Medical Research Involving ‘Human Subjects”, adopted by the 18 World Medical Assembly, Helsinki, Finland, June 1964, amended most recently by the 64 World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state ethical approval was given, by whom and the relevant Judgement</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was and that subjects gave informed consent to the work. “Journal of Gerontology and Geriatrics” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patients</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> records either a statement of approval or a statement exemption from the Committee is required. </span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Ref N° of the Ethical Committee Approval must be indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>. The study was approved by the Institutional Ethical Committee (the Name of the Institution must indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>) and this is clearly stated in the Methods section of the article.</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements,</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses reasonable attorney</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): “</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited</em></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">”.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>PRIVACY POLICY STATEMENT. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Personal data of the author will be managed by the Publisher in full compliance with the legislation on the privacy protection (art. 13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the author believes that processing of his/her own personal data infringes GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: http://www.jgerontology-geriatrics.com/informativa-privacy-privacy-policy/</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>FINANCIAL DISCLOSURE. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">All authors must state any information that may be perceived as potential conflict of interest. must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with company or its products, royalties, donation of medical equipment, etc.) with any organization that to any author</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s knowledge direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated Editor as confidential while the paper is under review, and will not be made known to Reviewers. Please indicate on the </span></span></span><strong><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Authorship</span></span></span> <span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Statement Form </span></span></span></a></strong><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">whether or not you have or may have such a conflict of interest regarding the content of this article and nature of it.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"> </p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><a name="_GoBack"></a> <span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>COPYRIGHT TRANSFER AGREEMENT</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">. (a) Authors assign to “Journal of Gerontology and Geriatrics”, all copyright in and to including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) own works, including the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) personal web home and to make copies of all or part of the Work for the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) use for lecture or classroom purposes. The corresponding declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content article rests upon the authors.</span></span></span></p>Effect of vestibular therapy as an adjunct to cognitive therapy to improve cognition in elderly with mild cognitive impairment (MCI): A Randomized Controlled Trial
https://www.jgerontology-geriatrics.com/article/view/762
<p><strong>Background and aims.</strong> The rate of population aging is drastically accelerating globally, having significant social, economic, and health repercussions. The prevalence of aging-related illnesses, such as mild cognitive impairment (MCI), will rise in elderly population as they get older, highlighting necessity of developing new treatment methods to stop MCI. This study aimed to determine effect of vestibular therapy as an adjunct to cognitive therapy to improve cognition in elderly with MCI. <br><strong>Methods</strong>. This was a three-armed, randomized controlled trial. The study was conducted with an estimated sample size of 36. After eligibility screening, participants were randomly assigned to vestibular therapy as an adjunct to cognitive therapy (VT+CT), cognitive therapy (CT) alone, and a control group. Participants in VT+CT group received vestibular therapy and computerized brain program. The CT alone group received a computerized brain program only. Primary outcome measures were ERP-P300, and Digit Symbol Substitution Test (DSST), and secondary outcomes included Stroop Color Word Test (SCWT) and Trail Making Test. Data was collected at baseline, 8th week, and 2 weeks after intervention. <br><strong>Results</strong>. VT+CT resulted in greater improvement in measures of cognition including ERP-P300 latency (p < 0.03) and its amplitude (p < 0.04), DSST (p < 0.00), and TMT-B (p < 0.00) as compared to CT alone, and control group.<br><strong>Conclusions</strong>. Given the superior effects in favor of VT+CT, It could reliably be argued that incorporating vestibular therapy in intervention regimen may yield greater improvements in cognition as evident in present study on measures of cognition like ERP-P300, DSST, and TMT-B in elderly with MCI.</p>Abhishek GoswamiChhavi Arora SehgalMajumi M. NoohuSarah ParveenMuhammad Azharuddin
Copyright (c) 2024 JOURNAL OF GERONTOLOGY AND GERIATRICS
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
2024-11-152024-11-157217318410.36150/2499-6564-N762Correlation between muscle masses measured by chest computed tomography and bioelectrical impedance analysis in older adults
https://www.jgerontology-geriatrics.com/article/view/790
<p><strong>Background and aims</strong>. There is a scarcity of research investigating the relationship between thoracic muscles and bioelectrical impedance analysis (BIA)-measured muscle mass specifically in older adults. Thus, the objective of this study is to assess the association between muscle measurements obtained from chest computed tomography (CT) scans and BIA in older adults. <br><strong>Methods</strong>. The retrospective study included outpatients who previously applied to the geriatrics outpatient clinic of a university hospital, who were evaluated with BIA and who had a chest CT for any reason within 3 months before or after the BIA. Cross-sectional muscle area at Th10 and Th12 was obtained from chest CT images.<br><strong>Results</strong>. The median age of the 83 patients was 73.0 (25p-75p: 69- 79), and 51.8% (n = 43) were female. By CT, from Th10 median for cross-sectional area (CSA) was 81.7 cm<sup>2</sup> (25p-75p: 61.5-95.3); from Th12, median for CSA was 93.1 cm<sup>2</sup> (25p-75p: 70-107.6). At both thoracic vertebrae levels, muscle masses were correlated with muscle mass obtained by BIA in all participants, those with normal handgrip strength, those who were obese and non-obese, and those with normal SMI. <br><strong>Conclusions</strong>. Muscle masses measured with BIA and CT correlated in older adults. It should be noticed that the thoracic muscles will also diminish if muscle mass measured by BIA decreases in older adults. Since BIA offers significant advantages in terms of non-invasiveness, portability, cost, time efficiency, ease of use and safety profile it can be a valid alternative to CT scans for thoracic muscle mass measurement.</p>Serdar CeylanMerve GunerArzu O. BaşYelda OzturkMeltem KocaOlgun DenizZeynep KahyaogluCennet YanardagBurcu B. DoguMeltem G. HalilMustafa CankurtaranGamze DurhanCafer Balcı
Copyright (c) 2024 JOURNAL OF GERONTOLOGY AND GERIATRICS
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
2024-11-152024-11-157218519210.36150/2499-6564-N790Long-term survival in frail older adults sustaining a hip fracture: does the perioperative period really matter?
https://www.jgerontology-geriatrics.com/article/view/777
<p style="font-weight: 400;"><strong>Purpose</strong>. Hip fractures in older adults are a major challenge for public health, it is associated with increased morbidity and mortality, especially in frailty older adults. An accurate evaluation of preventable perioperative risk factors is essential to optimize care pathways and clinical outcomes. This study aims to gauge evidence on the predictive accuracy of perioperative variables, including the Nottingham Hip Fracture Score (NHFS), on overall long-term survival (OS) in frail, hospitalized hip-fractured older adults. <br><strong>Methods</strong>. From March 2020 to September 2021, 433 elderly patients with hip fractures received multidisciplinary orthogeriatric care in Policlinic San Martino Hospital (Genova, Italy). Enrolled patients received geriatric assessment (CGA) within 24 hours from hospital admission and their medical conditions were assessed alongside post-operative complications and survival rates. Statistical analyses, including Cox models, evaluated factor influencing overall survival. <br><strong>Results</strong>. The patients’ most prevalent clinical phenotype was frailty, sustained by loss of muscle strength, malnutrition and functional disability. This phenotype reflects the unique demographic of the Liguria region (Italy) with the highest proportion of oldest-old (≥ 85 years) and frail individuals in the nation. Results showed NHFS > 5, vitamin D deficiency and delayed verticalization as key predictive determinants of long-term mortality (up to 21 months). Resilience to perioperative stressors in frail hip-fractured patients is crucial to the success of treatments aimed at improving their physical recovery. <br><strong>Conclusions</strong>. Our research showed that targeting preventable factors during surgery can greatly impact the functional reserve of frail elderly patients, influencing their recovery and long-term outcomes, including mortality rates.</p>Alessandra GerosaSilvia OttavianiLuca TagliaficoElena PageMonica PizzoniaChiara GiannottiAndrea CasabellaAlessio SignoriAlessio NencioniFiammetta Monacelli
Copyright (c) 2024 JOURNAL OF GERONTOLOGY AND GERIATRICS
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
2024-12-172024-12-177219320310.36150/2499-6564-N777Exergames in neurocognitive disease management in elderly: a narrative review of therapeutic benefits and applications
https://www.jgerontology-geriatrics.com/article/view/753
<p><strong>Objective</strong>. Recent advancements in understanding neurodegenerative diseases highlight their global impact, affecting about 55 million individuals. Mild Neurocognitive disorder (MND) underscores the urgency for early intervention. Nonpharmacological approaches, including exergames, show promise in enhancing cognitive and physical functions. This review explores exergames’ potential in Neurocognitive disorder intervention. <br><strong>Methods</strong>. The review covered publications from 2012 to December 2023, from PubMed, Scopus, Google Scholar, Web of Science, and PEdro. Papers were selected using key words like “exergame”, “dementia”,” neurocognitive disorder” “Alzheimer’s Disease”, “cognitive function”, “balance”, and “walking”. <br><strong>Results</strong>. This study focused on identifying studies using exergames in Neurocognitive disorder (NCD) support. Most studies (22/28) included control group comparisons. Some focused on cognitive function (3/27), physical abilities like balance and walking (4/27), or both (12/27). A study investigated cognitive function and electroencephalogram (EEG). Additionally, a pilot study examined cognitive functions and oxidative stress (OxS). The Nintendo Wii and Microsoft Kinect were commonly used, alongside iPACES, iPACES 2.0, Physiomat, Bike and Fiets Labyrint, IREX, LegSys, BioSensics, Cosmed EuroBike 320, Dividat Senso, Valve Index (HMD), and Hexer Heart. <br><strong>Conclusions</strong>. Exergames emerge as a viable alternative to traditional physical exercise, offering easy accessibility and active participant engagement, thus promoting greater adherence. Utilizing low-cost devices, these games are readily available and applicable in specialized centers and at home with caregiver assistance, highlighting their adaptability during circumstances such as pandemics.</p>Annalisa D'ErmoTommaso Di LiberoElisa LangianoBeatrice TostiStefano CorradoPierluigi DiotaiutiLuigi FattoriniAngelo Rodio
Copyright (c) 2024 JOURNAL OF GERONTOLOGY AND GERIATRICS
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
2024-11-152024-11-157220421410.36150/2499-6564-N753